BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simões e Silva AC, Miranda AS, Rocha NP, Teixeira AL. Renin angiotensin system in liver diseases: Friend or foe? World J Gastroenterol 2017; 23(19): 3396-3406 [PMID: 28596676 DOI: 10.3748/wjg.v23.i19.3396] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 37] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Ge P, Yao X, Li J, Jiang R, Dai J, Zhang L. Diminazene aceturate alleviated lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice. Biomedicine & Pharmacotherapy 2018;98:142-8. [DOI: 10.1016/j.biopha.2017.12.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
2 Wieruszewski PM, Sims CR, Daly RC, Taner T, Wittwer ED. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology. Journal of Cardiothoracic and Vascular Anesthesia 2019;33:2366-7. [DOI: 10.1053/j.jvca.2019.03.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
3 Coleman PJ, Nissen AP, Kim DE, Ainsworth CR, McCurdy MT, Mazzeffi MA, Chow JH. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock. Semin Cardiothorac Vasc Anesth 2020;24:266-72. [PMID: 31540560 DOI: 10.1177/1089253219877876] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
4 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
6 Noh MR, Jang HS, Kim J, Padanilam BJ. Renal Sympathetic Nerve-Derived Signaling in Acute and Chronic kidney Diseases. Int J Mol Sci 2020;21:E1647. [PMID: 32121260 DOI: 10.3390/ijms21051647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
7 Mehranfard D, Perez G, Rodriguez A, Ladna JM, Neagra CT, Goldstein B, Carroll T, Tran A, Trivedi M, Speth RC. Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer. J Renin Angiotensin Aldosterone Syst 2021;2021:9987115. [PMID: 34285715 DOI: 10.1155/2021/9987115] [Reference Citation Analysis]
8 Morsy MA, Abdel-Gaber SA, Rifaai RA, Mohammed MM, Nair AB, Abdelzaher WY. Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression. Biomed Pharmacother 2022;145:112374. [PMID: 34915671 DOI: 10.1016/j.biopha.2021.112374] [Reference Citation Analysis]
9 Pidikova P, Svitok P, Herichova I. Sex and salt intake dependent renin-angiotensin plasticity in the liver of the rat. Endocr Regul 2019;53:178-86. [PMID: 31517631 DOI: 10.2478/enr-2019-0018] [Reference Citation Analysis]
10 de Oliveira da Silva B, Alberici LC, Ramos LF, Silva CM, da Silveira MB, Dechant CRP, Friedman SL, Sakane KK, Gonçalves LR, Moraes KCM. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1-7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism. Int J Biochem Cell Biol 2018;98:137-55. [PMID: 29524604 DOI: 10.1016/j.biocel.2018.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
11 Miranda AS, Simões e Silva AC. Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis. World J Gastroenterol 2017; 23(48): 8439-8442 [PMID: 29358853 DOI: 10.3748/wjg.v23.i48.8439] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
12 Warner FJ, Rajapaksha H, Shackel N, Herath CB. ACE2: from protection of liver disease to propagation of COVID-19. Clin Sci (Lond). 2020;134:3137-3158. [PMID: 33284956 DOI: 10.1042/cs20201268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Davis TME, Peters KE, Chubb SAP, Adams LA, Jeffrey GP, Davis WA. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes Study. J Clin Med 2020;9:E3409. [PMID: 33114323 DOI: 10.3390/jcm9113409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Chow JH, Wittwer ED, Wieruszewski PM, Khanna AK. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00537-7. [PMID: 33875258 DOI: 10.1016/j.jtcvs.2021.02.097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kim KM, Roh JH, Lee S, Yoon JH. Clinical implications of renin-angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease. Sci Rep 2021;11:2884. [PMID: 33536442 DOI: 10.1038/s41598-021-81959-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mantovani A, Byrne CD, Benfari G, Bonapace S, Simon TG, Targher G. Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week. J Am Coll Cardiol 2022;79:180-91. [PMID: 35027111 DOI: 10.1016/j.jacc.2021.11.007] [Reference Citation Analysis]
17 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Nehme A, Zouein FA, Zayeri ZD, Zibara K. An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology.J Cardiovasc Dev Dis. 2019;6. [PMID: 30934934 DOI: 10.3390/jcdd6020014] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 22.7] [Reference Citation Analysis]
19 Dimitroglou Y, Aggeli C, Alexopoulou A, Mavrogeni S, Tousoulis D. Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives. J Clin Med 2019;8:E2132. [PMID: 31817014 DOI: 10.3390/jcm8122132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lumlertgul N, Ostermann M. Roles of angiotensin II as vasopressor in vasodilatory shock. Future Cardiol 2020;16:569-83. [PMID: 32462921 DOI: 10.2217/fca-2020-0019] [Reference Citation Analysis]
21 Di Pascoli M, La Mura V. Renin-angiotensin-aldosterone system in cirrhosis: There's room to try!Dig Liver Dis. 2019;51:297-298. [PMID: 30220630 DOI: 10.1016/j.dld.2018.07.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Philips CA, Rela M, Soin AS, Gupta S, Surendran S, Augustine P. Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:947-59. [PMID: 34966658 DOI: 10.14218/JCTH.2021.00228] [Reference Citation Analysis]
23 Hammoud SH, Wehbe Z, Abdelhady S, Kobeissy F, Eid AH, El-Yazbi AF. Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity. Mol Pharmacol. 2021;99:17-28. [PMID: 33082267 DOI: 10.1124/molpharm.120.000119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Mastoor Z, Diz-chaves Y, González-matías LC, Mallo F. Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins. Metabolites 2022;12:411. [DOI: 10.3390/metabo12050411] [Reference Citation Analysis]
25 Gunarathne LS, Angus PW, Herath CB. Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats. Front Physiol. 2019;10:1169. [PMID: 31607942 DOI: 10.3389/fphys.2019.01169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Miyauchi K, Nakai T, Saito S, Yamamoto T, Sato K, Kato K, Nezu M, Miyazaki M, Ito S, Yamamoto M, Suzuki N. Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions. EBioMedicine 2021;64:103209. [PMID: 33508746 DOI: 10.1016/j.ebiom.2021.103209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J Clin Med 2021;10:702. [PMID: 33670126 DOI: 10.3390/jcm10040702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Takeda S, Kaji K, Nishimura N, Enomoto M, Fujimoto Y, Murata K, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched-Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic Rats. Mol Nutr Food Res 2021;65:e2100526. [PMID: 34687151 DOI: 10.1002/mnfr.202100526] [Reference Citation Analysis]
29 Ehrlich L, Scrushy M, Meng F, Lairmore TC, Alpini G, Glaser S. Biliary epithelium: A neuroendocrine compartment in cholestatic liver disease. Clin Res Hepatol Gastroenterol 2018;42:296-305. [PMID: 29678444 DOI: 10.1016/j.clinre.2018.03.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hall KC, Bernier SG, Jacobson S, Liu G, Zhang PY, Sarno R, Catanzano V, Currie MG, Masferrer JL. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. Proc Natl Acad Sci U S A 2019;116:11057-62. [PMID: 31085647 DOI: 10.1073/pnas.1821045116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
31 Liu PMF, de Carvalho ST, Fradico PF, Cazumbá MLB, Campos RGB, Simões E Silva AC. Hepatorenal syndrome in children: a review. Pediatr Nephrol 2021;36:2203-15. [PMID: 33001296 DOI: 10.1007/s00467-020-04762-6] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 El-Sayed LA, Osama E, Mehesen MN, Rashed LA, Aboulkhair AG, Omar AI, Shams Eldeen AM. Contribution of angiotensin II in hepatic ischemia /reperfusion induced lung injury: Acute versus chronic usage of captopril. Pulm Pharmacol Ther 2020;60:101888. [PMID: 31923459 DOI: 10.1016/j.pupt.2020.101888] [Reference Citation Analysis]
33 Yang T, Chen Y, Liu J, Zhao H, Vaziri ND, Guo Y, Zhao Y. Natural products against renin-angiotensin system for antifibrosis therapy. European Journal of Medicinal Chemistry 2019;179:623-33. [DOI: 10.1016/j.ejmech.2019.06.091] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
34 Han B, Lee GB, Yim SY, Cho K, Shin KE, Kim J, Park Y, Han K, Kim Y. Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study. Diagnostics 2022;12:663. [DOI: 10.3390/diagnostics12030663] [Reference Citation Analysis]
35 Pucci F, Annoni F, Dos Santos RAS, Taccone FS, Rooman M. Quantifying Renin-Angiotensin-System Alterations in COVID-19. Cells 2021;10:2755. [PMID: 34685735 DOI: 10.3390/cells10102755] [Reference Citation Analysis]
36 Zhang HF, Gao X, Wang X, Chen X, Huang Y, Wang L, Xu ZW. The mechanisms of renin-angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures. Biomed Pharmacother 2021;141:111868. [PMID: 34328104 DOI: 10.1016/j.biopha.2021.111868] [Reference Citation Analysis]
37 Philips CA, Augustine P, Ahamed R, Rajesh S, George T, Valiathan GC, John SK. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering'. J Clin Transl Hepatol 2019;7:371-83. [PMID: 31915607 DOI: 10.14218/JCTH.2019.00034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Simões E Silva AC, Lanza K, Palmeira VA, Costa LB, Flynn JT. 2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus. Pediatr Nephrol 2021;36:1407-26. [PMID: 32995920 DOI: 10.1007/s00467-020-04759-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Gonzalez E, Azkargorta M, Garcia-Vallicrosa C, Prieto-Elordui J, Elortza F, Blanco-Sampascual S, Falcon-Perez JM. Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease? Int J Biol Sci 2021;17:1864-77. [PMID: 34131392 DOI: 10.7150/ijbs.59725] [Reference Citation Analysis]
40 Acheampong DO, Barffour IK, Boye A, Aninagyei E, Ocansey S, Morna MT. Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects. Biomed Pharmacother 2020;131:110748. [PMID: 33152916 DOI: 10.1016/j.biopha.2020.110748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
41 Running K, Weinberg D, Trudo W, Sullivan CL, Patel GP. Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report. A A Pract 2021;15:e01402. [PMID: 33577171 DOI: 10.1213/XAA.0000000000001402] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ryu T, Veilleux HD, Munday PL, Jung I, Donelson JM, Ravasi T. An Epigenetic Signature for Within-Generational Plasticity of a Reef Fish to Ocean Warming. Front Mar Sci 2020;7:284. [DOI: 10.3389/fmars.2020.00284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
43 Pizoń T, Rajzer M, Wojciechowska W, Wach-Pizoń M, Drożdż T, Wróbel K, Gruszka K, Rojek M, Kameczura T, Jurczyszyn A, Kąkol J, Czarnecka D. The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension. J Renin Angiotensin Aldosterone Syst 2018;19:1470320318810022. [PMID: 30404585 DOI: 10.1177/1470320318810022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yeh H, Chiang CC, Yen TH. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021; 27(26): 4104-4142 [PMID: 34326614 DOI: 10.3748/wjg.v27.i26.4104] [Reference Citation Analysis]
45 Kim KM, Roh JH, Lee S, Yoon JH. Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study. Clin Res Hepatol Gastroenterol 2021;45:101510. [PMID: 33272886 DOI: 10.1016/j.clinre.2020.07.015] [Reference Citation Analysis]